Marsili Syndrome: A mutation in the ZFHX2 gene leaves Italian family painless

Last Updated on

December 21, 2017 – No pain on gain. This headline might not at all apply for this Italian family. In a paper just published in the Journal Brain, researchers describe  a mysterious genetic mutation that effectively negates the sensation of pain, enabling people with the rare anomaly to persevere effortlessly through extreme physical discomfort. A variant of the ZFHX2 has been identified in an Italian family where members of the family belonging to different generations feel almost no pain even when seriously injured. The authors of the  related research paper in Brain have coined this familial phenotypical observation “human pain insensitivity disorder  caused by a point mutation in ZFHX2”, better and more memorable, the “Marsili Syndrome”, after the family.

Congenital insensitivity to pain (CIP), also known as congenital analgesia, has been recognised before and represents one or more rare conditions in which a person cannot feel (and has never felt) physical pain. In some cases, the underlying molecular (genetic) factors involved have been identified. For example, the SCN9A gene seems to play an important role in these rare conditions. Thus, SCN9A codes for the voltage-gated sodium-channel type IX α subunit, known as Nav1.7. which is located in peripheral neurons and plays an important role in action potential production in these cells. Recent genetic studies have identified Nav1.7 dysfunction in different human pain disorders. Nonsense mutations in Nav1.7 result in loss of Nav1.7 function and a condition known as channelopathy-associated insensitivity to pain, where affected individuals are unable to feel physical pain. Quite to the contrary, gain-of-function missense mutations in Nav1.7 have been shown to cause primary erythermalgia (PE) and paroxysmal extreme pain disorder (PEPD).

Generally, physical pain constitutes a protective sensation alerting individuals towards injuries (fractures, etc.), frank organ failures, and emerging diseases, to name only a few. Emotional pain is not even considered in this context here. Thus, while some may find a condition where one does not feel pain as plain cool, finding described for this Italian family here might represent a two-sided sword. A point in case would be the family’s  24-year-old son who plays soccer (football). His incurred sports injuries are masked, because he does not feel when he gets injured; recently X-rays have shown that he carries numerous micro-fractures in both ankles. Similarly, the sons 78-year-old grandmother was suffering from fractures that were only much later diagnosed, meaning they harden naturally but did not heal properly.

At that point in time, it is not yet clear how exactly the identified ZFHX2 mutation interrupts pain signalling. The research team resorted to animal experiments to gain first insights on how the ZFHX2 variant molecularly affects pain processing in mice. Thus, animals bred to not have the gene at all showed reduced pain sensitivity when pressure was applied to their tails, but were still receptive to high heat. When other mice were bred to possess the ZFHX2 mutation, they exhibited the same low sensitivity to high heat as the family member have.

Overall, identifying this mutation and clarifying that it contributes to the family’s pain insensitivity may have opened, we have opened up new routes to drug discovery for pain relief. Understanding exactly how the ZFHX2-mutation impacts pain sensitivity, and to understand what other downstream genes might be involved in pain signalling, ZFHX2 may be novel target for anti-pain drug development. May gene therapeutic approaches involving silencing of ZFHX2 in patients with severe and/or chronic pain disorders might be an future therapy option, apart from the more and more problematic opioid based treatments.

Tags: , , , , , , , , , , , , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Leave a Reply

Optional: Social Subscribe/Login

Notify of

Awesome blog you have here but I was wanting to know if you
knew of any discussion boards that cover the same topics discussed in this
article? I’d really love to be a part of group where I can get feed-back from other experienced individuals that share the same interest.
If you have any suggestions, please let me know.

Coconut Oil Benefits

It’s hard to come by knowledgeable people on this topic, but
you sound like you know what you’re talking about! Thanks

Health Benefits of Coconut Oil

This piece of writing is actually a good one it assists
new internet visitors, who are wishing in favor of blogging.


This design is spectacular! You most certainly know how
to keep a reader entertained. Between your wit and
your videos, I was almost moved to start my own blog (well,
almost…HaHa!) Fantastic job. I really enjoyed what you had to say,
and more than that, how you presented it. Too cool!

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • New candidate cancer genes identified using math models November 15, 2019
    Computational modeling is the use of computers to simulate and study the behavior of complex systems. Computational approaches are widely adopted in the bioimedical sciences and can be used to sift through large volumes of complex data to extract recurrent patterns that may point to a disease's causes and effects.
  • Turning 'junk' DNA into gold November 15, 2019
    Mining the rich uncharted territory of the genome or genetic material of a cancer cell has yielded gold for Princess Margaret scientists: new protein targets for drug development against prostate cancer.
  • Researchers take first step toward genetic test for childhood short-sightedness November 15, 2019
    Researchers from the Universities of Cardiff and Bristol have devised a test that could in future help to identify children at risk of developing a very common eye condition.
  • Researchers link sisters' paralysis to an 'extremely rare' genetic variant November 15, 2019
    Following a nearly 25-year search across three continents, parents of a pair of sisters—who as children slowly became paralyzed from the waist down—finally have a diagnosis, according to researchers at University of Southern California (USC) and Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
  • Genetic variation in individual brain cell types may predict disease risk November 15, 2019
    One might think that the primary cause of most genetically linked diseases comes from mutations in coding DNA—alterations in coding regions of the genome that can lead directly to changes in the expression of particular proteins important for a healthy body. But the majority of human DNA is non-coding DNA—regions of DNA that do not […]
  • Teens with heart disease improve exercise capacity in large clinical trial November 17, 2019
    The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects. A study leader says the physiologic benefits represent a milestone in the care of those who have undergone the Fontan procedure, a palliative operation for single-ventricle […]
  • Rare genetic variants predispose to sudden cardiac death November 16, 2019
    By identifying rare DNA variants that substantially increase risk of sudden cardiac death, researchers have laid the foundation for efforts to identify individuals who could benefit from prevention strategies prior to experiencing symptoms.
  • Early diagnosis of pregnancy-associated heart disease linked to better outcomes November 16, 2019
    Women who are diagnosed with peripartum cardiomyopathy (PPCM) during late pregnancy or within a month following delivery are more likely to experience restored cardiac function and improved outcomes compared to those who are diagnosed later in the postpartum period, according to a new study. The findings underscore the need for increased awareness and monitoring of […]
  • Intermittent fasting increases longevity in cardiac catheterization patients November 16, 2019
    In a new study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have found that cardiac catheterization patients who practiced regular intermittent fasting lived longer than patients who don't.
  • New catalysts remove NOx pollutants at lower temperatures November 16, 2019
    Scientists from Tokyo Metropolitan University have developed a low-temperature catalyst for removing NOx gas from industrial exhaust using ammonia. Composed of bulk 'defective' vanadium oxide instead of vanadium oxides supported on titanium oxide like in commercial catalysts, the catalyst works at lower temperatures (< 150 degrees Celsius) with much higher efficiency. The team demonstrated a […]